BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11188994)

  • 21. Pulmonary manifestations of pyoderma gangrenosum: 2 cases and a review of the literature.
    Gade M; Studstrup F; Andersen AK; Hilberg O; Fogh C; Bendstrup E
    Respir Med; 2015 Apr; 109(4):443-50. PubMed ID: 25622759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyoderma gangrenosum occurring near an arteriovenous dialysis shunt.
    Sangiray H; Nguyen JC; Turiansky GW; Norwood C
    Int J Dermatol; 2006 Jul; 45(7):851-3. PubMed ID: 16863525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sclerokeratitis and facial skin lesions: a case report of pyoderma gangrenosum and its response to dapsone therapy.
    Teasley LA; Foster CS; Baltatzis S
    Cornea; 2007 Feb; 26(2):215-9. PubMed ID: 17251816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cogan's syndrome with pyoderma gangrenosum: management of two uncommon disorders with aggressive presentation in a patient.
    Chua EP; Mallett RB; Dahiya S
    BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29925554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pyoderma gangrenosum in a patient with psoriatic arthritis.
    Spangler JG
    J Am Board Fam Pract; 2001; 14(6):466-9. PubMed ID: 11757891
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of etanercept in treatment of pyoderma gangrenosum in a patient with autoimmune hepatitis.
    Goldenberg G; Jorizzo JL
    J Dermatolog Treat; 2005; 16(5-6):347-9. PubMed ID: 16428159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral ulcerative keratitis in association with sarcoidosis.
    Harthan JS; Reeder RE
    Cont Lens Anterior Eye; 2013 Dec; 36(6):313-7. PubMed ID: 23993305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of infliximab in a patient with pyoderma gangrenosum and rheumatoid arthritis.
    Tada M; Nakanishi T; Hirata C; Okano T; Sugioka Y; Wakitani S; Nakamura H; Koike T
    Mod Rheumatol; 2010 Dec; 20(6):598-601. PubMed ID: 20680379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pyoderma gangrenosum of the upper eyelid.
    Bromeo AJ; Suller A
    BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31289150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vegetative pyoderma gangrenosum.
    Kim RH; Lewin J; Hale CS; Meehan SA; Stein J; Ramachandran S
    Dermatol Online J; 2014 Dec; 20(12):. PubMed ID: 25526339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intestinal Behçet's disease with pyoderma gangrenosum successfully treated with the combination therapy of adalimumab and glucocorticoids.
    Kashiwado Y; Uchino A; Ota T; Nagano S
    Mod Rheumatol; 2018 Sep; 28(5):901-905. PubMed ID: 27142127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel therapy for the treatment of pyoderma gangrenosum.
    Azizan NZ; Gangaram HB; Hussein SH
    Med J Malaysia; 2008 Mar; 63(1):51-4. PubMed ID: 18935734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Topical negative pressure and skin transplantation for the treatment of pyoderma gangrenosum].
    Gámiz RC; Nielsen AM
    Ugeskr Laeger; 2011 Aug; 173(35):2132-3. PubMed ID: 21884666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pyoderma gangrenosum].
    Herberger K
    Hautarzt; 2016 Sep; 67(9):753-63. PubMed ID: 27492434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An analysis of therapeutic decision making regarding immunosuppressive chemotherapy for peripheral ulcerative keratitis.
    Tauber J; Sainz de la Maza M; Hoang-Xuan T; Foster CS
    Cornea; 1990 Jan; 9(1):66-73. PubMed ID: 2297997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral ulcerative keratitis in sarcoidosis: a case report.
    Siracuse-Lee D; Saffra N
    Cornea; 2006 Jun; 25(5):618-20. PubMed ID: 16783154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pyoderma gangrenosum of the eyelid: report of two cases and review of the literature.
    Saito N; Yanagi T; Akiyama M; Lin HY; Kasai S; Fujita Y; Yamane N; Inokuma D; Kase S; Ono K; Minakawa H; Shimizu H
    Dermatology; 2010; 221(3):211-5. PubMed ID: 20720387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pyoderma gangrenosum: clinical characteristics, associated diseases, and responses to treatment in a retrospective cohort study of 31 patients.
    Vacas AS; Torre AC; Bollea-Garlatti ML; Warley F; Galimberti RL
    Int J Dermatol; 2017 Apr; 56(4):386-391. PubMed ID: 28295267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pyoderma gangrenosum in association with juvenile rheumatoid arthritis.
    Yayli S; Bahadir S; Alpay K; Cimşit G; Cobanoğlu U; Tosun M
    J Dermatol; 2005 Oct; 32(10):827-30. PubMed ID: 16361736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recalcitrant cases of pyoderma gangrenosum, responding dramatically to systemic tacrolimus.
    Sadati MS; Dastgheib L; Aflaki E
    G Ital Dermatol Venereol; 2017 Jun; 152(3):308-310. PubMed ID: 28409579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.